Samira Sakhia Insider Profile

Samira Sakhia, Director at Antibe Therapeutics, holds 193.27K shares in Knight Therapeutics (Ticker: KHTRF), holds 13.78K shares in Nuvo Pharmaceuticals (Ticker: TSE:MRV), holds 250.00K shares in Antibe Therapeutics (Ticker: ATBPF).
Samira Sakhia

Samira Sakhia
Antibe Therapeutics (ATBPF)

Ranked #70,052 out of 99,644 Corporate Insiders

Profitable Transactions

4 out of 15 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Samira Sakhia's holdings

Insider Roles

Knight Therapeutics
President & Chief Executive Officer
Antibe Therapeutics
Roles that Samira Sakhia holds in companies

Most Profitable Insider Trade

Nuvo Pharmaceuticals
Rating:Informative Buy
Date:Jan 07, 2016 - Jan 07, 2017
The most profitable trade made by Samira Sakhia

Samira Sakhia's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Antibe Therapeutics
Apr 07, 2015
Informative Buy
Knight Therapeutics
Sep 20, 2023
President & Chief Executive Officer
Uninformative Buy
Nuvo Pharmaceuticals
Mar 07, 2016
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Samira Sakhia's performance on stock

Samira Sakhia insider profile FAQ

What is the percentage of profitable transactions made by Samira Sakhia?
The percentage of profitable transactions made by Samira Sakhia is 27%.
    What is the average return per transaction made by Samira Sakhia?
    The average return per transaction made by Samira Sakhia is -5.80%.
      What stocks does Samira Sakhia hold?
      Samira Sakhia holds: ATBPF, KHTRF, TSE:MRV stocks.
        What was Samira Sakhia’s latest transaction?
        Samira Sakhia latest transaction was an Uninformative Buy of $14.72K.
          What was Samira Sakhia's most profitable transaction?
          Samira Sakhia’s most profitable transaction was an Informative Buy of TSE:MRV stock on January 7, 2016. The return on the trade was 53.00%.
            What is Samira Sakhia's role in Antibe Therapeutics?
            Samira Sakhia's role in Antibe Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.